Login / Signup

PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt.

Uzodinma U UcheAnn R PiccirilloShunsuke KataokaStephanie J GrebinoskiLouise M D'CruzLawrence P Kane
Published in: The Journal of experimental medicine (2018)
Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.
Keyphrases
  • pi k akt
  • signaling pathway
  • mouse model
  • transcription factor
  • listeria monocytogenes
  • multiple sclerosis
  • metabolic syndrome
  • cell death
  • adipose tissue
  • young adults
  • reactive oxygen species